Lindbrook Capital, LLC Bio Xcel Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$17.7 - $33.24 $389 - $731	22 New	22 $0
Q2 2022 Aug 01, 2022	SELL	$9.03 - $21.55 $866 - $2,068	-96 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$15.0 - $22.83 $1,440 - $2,191	96 New	96 $2,000
Q4 2021 Jan 18, 2022	SELL	$20.12 - $35.09 $40,240 - $70,180	-2,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$23.84 - $32.03 $35,760 - $48,045	1,500 Added 300.0%	2,000 $61,000
Q2 2021 Jul 27, 2021	SELL	$29.06 - $38.83 $7,613 - $10,173	-262 Reduced 34.38%	500 $15,000
Q1 2021 Apr 28, 2021	BUY	$39.04 - $64.6 $22,565 - $37,338	578 Added 314.13%	762 $33,000
Q4 2020 Jan 27, 2021	SELL	$42.46 - $56.58 $77,107 - $102,749	-1,816 Reduced 90.8%	184 $9,000
Q3 2020 Nov 03, 2020	BUY	$37.44 - $64.63 $74,880 - $129,259	2,000 New	2,000 $87,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.